Contents
2.In addition to the participants listed in paragraph 1, where the joint scientific consultation on medicinal products is carried out in parallel with the scientific advice, the following participants shall be invited to the meeting referred to in Article 18(8) of Regulation (EU) 2021/2282:
(a)the coordinators for scientific advice;
(b)other members of the scientific advice working party of the Committee for Medicinal Products for Human Use than the ones listed in point (a);
(c)the staff members of the European Medicines Agency responsible for providing secretariat support to the scientific advice working party.
On request from the European Medicines Agency, other experts selected in accordance with the relevant rules of the European Medicines Agency to participate during the scientific advice may be invited to the meeting for an exchange of views.
Source: EUR-Lex, © European Union, 1998-2026. Reuse authorised under Decision 2011/833/EU.